Medical Aesthetics Market

Market Definition

The market encompasses a broad range of non-invasive and minimally invasive treatments aimed at improving physical appearance and skin health. This includes procedures such as botulinum toxin injections, dermal fillers, laser treatments, and skin rejuvenation therapies.

The market serves both aesthetic enhancements and medical needs, catering to individuals seeking cosmetic improvements as well as treatments for skin-related medical conditions.

The report explores key drivers of market development, offering detailed regional analysis and a comprehensive overview of the competitive landscape shaping future opportunities.

Medical Aesthetics Market Overview

The global medical aesthetics market size was valued at USD 15.46 billion in 2023 and is projected to grow from USD 17.15 billion in 2024 to USD 39.22 billion by 2031, exhibiting a CAGR of 12.55% during the forecast period.

The market is registering significant growth, due to the rising consumer demand for non-surgical cosmetic procedures, advancements in technology, and increasing awareness of aesthetic treatments. Factors such as a growing emphasis on self-care and an aging population seeking anti-aging solutions contribute to market expansion.

Major companies operating in the medical aesthetics industry are AbbVie Inc., Galderma, Merz Pharma, Johnson & Johnson Services, Inc., Bausch Health Companies Inc., Lumenis Be Ltd., Cynosure, LLC, Sisram Medical Ltd, Cutera, Inc., Lutronic Corporation, Candela Corporation, Aerolase, Sciton, El.En. S.p.A., and BTL.

Additionally, the development of innovative, minimally invasive treatments and the increasing popularity of procedures like Botox, dermal fillers, and laser treatments have broadened the market appeal. The growth of medical tourism, particularly for aesthetic procedures, also boosts demand, making medical aesthetics a dynamic and evolving market.

• In October 2024, Allergan Aesthetics made JUVÉDERM VOLUMA XC available nationwide for the treatment of moderate to severe temple hollowing in adults aged over 21 years. Following FDA approval, the product became the first and only hyaluronic acid filler approved for this indication, expanding Allergan’s portfolio and supporting pan-facial aesthetic treatment approaches.

Key Highlights:

1. The medical aesthetics industry size was valued at USD 15.46 billion in 2023.
2. The market is projected to grow at a CAGR of 12.55% from 2024 to 2031.
3. North America held a market share of 37.33% in 2023, with a valuation of USD 5.77 billion.
4. The botulinum toxin segment garnered USD 5.74 billion in revenue in 2023.
5. The facial aesthetics segment is expected to reach USD 14.82 billion by 2031.
6. The market in Asia Pacific is anticipated to grow at a CAGR of 13.38% during the forecast period.

 Market Driver

"Technological Advancements"

The medical aesthetics market is registering significant growth, due to rapid advancements in technology and innovations in aesthetic procedures, minimally invasive treatments, and personalized skincare solutions.

Non-invasive treatments are becoming popular, as they offer effective solutions with minimal downtime and discomfort. Innovations such as radiofrequency devices, advanced lasers, and ultrasound technologies are transforming how aesthetic procedures are performed, enhancing patient satisfaction.

These technological advancements are enhancing the overall effectiveness of procedures, expanding their accessibility & affordability and making aesthetic treatments appealing to a broad range of consumers.

• In November 2024, Cartessa Aesthetics and Classys, Inc. partnered to bring EVERESSE, a monopolar radiofrequency technology, to the U.S. market. The collaboration aims to provide an advanced, non-invasive solution for skin tightening and lifting, offering improved comfort, efficiency, and results for patients.

Market Challenge

"Unskilled Professionals"

A significant challenge in the medical aesthetics market is the presence of unskilled or inadequately trained professionals. The growing demand for aesthetic treatments poses a risk of practitioners who lack the necessary qualifications and expertise to perform procedures. This can lead to suboptimal results, patient dissatisfaction, and even safety concerns.

Continuous training programs and regulatory oversight can ensure that only qualified professionals offer treatments. Additionally, patient safety and treatment outcomes can be significantly improved by promoting proper education and skill development within the industry.

• In February 2025, Allergan Aesthetics announced the launch of three new Allergan Medical Institute Training Centers in the U.S. The centers will offer comprehensive training programs designed to enhance clinical techniques, complications management, and business acumen of service providers, supporting the delivery of safe, effective aesthetic treatments and fostering patient satisfaction.

Market Trend

"Glass Skin Trend"

The medical aesthetics market is being shaped by the rising trend of achieving glass skin, which emphasizes a smooth, luminous, and translucent complexion. This trend is gaining momentum as consumers increasingly seek treatments that provide a radiant, youthful appearance with minimal effort.

The focus on achieving a dewy, hydrated skin look has driven the popularity of treatments like skin resurfacing, hydration facials, and light-based therapies. Beauty standards are evolving toward a flawless, natural glow, generating increased interest in solutions that promote skin health and luminosity, further accelerating market growth.

• In March 2025, Candela Corporation launched Glacē treatment at the American Academy of Dermatology (AAD) Annual Meeting. The advanced hydrodermabrasion solution, inspired by the glass skin trend, combines hydrodermabrasion, dual-mode cupping massage, and LED technology to enhance skin purification and hydration, offering a customizable treatment for various skin types and concerns.

Medical Aesthetics Market Report Snapshot

Segmentation	Details
By Product Type	Dermal Fillers, Botulinum Toxin, Microdermabrasion, Skin Rejuvenation Devices, Others
By Application	Body Contouring and Fat Reduction, Facial Aesthetics, Hair Removal, Breast Augmentation, Others
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

Market Segmentation

• By Product Type (Dermal Fillers, Botulinum Toxin, Microdermabrasion, Skin Rejuvenation Devices, and Others): The botulinum toxin segment earned USD 5.74 billion in 2023, due to its widespread use in non-surgical wrinkle treatments and high consumer demand for quick, effective aesthetic solutions.
• By Application (Body Contouring and Fat Reduction, Facial Aesthetics, Hair Removal, Breast Augmentation, and Others): The facial aesthetics segment held 35.13% share of the market in 2023, due to the growing demand for procedures that enhance facial features and restore youthful appearance with minimal downtime.

Medical Aesthetics Market Regional Analysis

Based on region, the market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America .

North America medical aesthetics market share stood at around 37.33% in 2023, with a valuation of USD 5.77 billion. The U.S. is the primary driver of this growth, with high consumer spending on cosmetic procedures.

Major cities like New York, Los Angeles, and Miami are hubs for aesthetic treatments, attracting both domestic and international clients. The U.S. also leads in advanced technologies, including botulinum toxin injections and dermal fillers.

The market in the region is fueled by the strong demand for facial rejuvenation, body contouring, and non-invasive procedures, reflecting a growing focus on enhancing appearance and maintaining a vibrant, refreshed look.

Additionally, the increasing prevalence of social media and influencer culture in the U.S. has created a heightened desire for aesthetic treatments, as individuals seek to achieve idealized beauty standards.

The medical aesthetics industry in Asia Pacific is expected to register the fastest growth, with a projected CAGR of 13.38% over the forecast period. This growth is fueled by the increasing awareness of cosmetic enhancements and a growing desire for youthful appearance, particularly in countries like Japan, South Korea, and China.

South Korea, known as the global hub for beauty treatments, contributes significantly to the market with its advanced technologies and high adoption rates of aesthetic procedures.

Furthermore, the increasing influence of social media in countries like India and China is driving the demand for facial aesthetics and body contouring. The availability of affordable aesthetic solutions in the region further accelerates the growth of the market.

• In January 2025, Shonan Beauty Clinic launched a proprietary translation app specialized for medical aesthetics staff and fully implemented its “Inbound-Focused Clinics” initiative. The app facilitates seamless communication with international patients, supporting the growing trend of medical tourism in Japan.

 Regulatory Frameworks

• In the U.S., the Food and Drug Administration (FDA) is the primary regulatory authority for medical aesthetics, including devices used to improve appearance. The FDA regulates devices intended for cosmetic purposes, such as those used for skin rejuvenation or body contouring, if they impact the structure or function of the body.
• In Japan, the regulatory authority for medical aesthetics is the Pharmaceuticals and Medical Devices Agency (PMDA), which operates under the Ministry of Health, Labour and Welfare (MHLW). The PMDA is responsible for reviewing the quality, safety, and efficacy of medical products, including those used in medical aesthetics.
• In India, the Central Drugs Standard Control Organization (CDSCO) regulates medical aesthetics. The CDSCO oversees the safety, efficacy, and quality of medical products, including those used in aesthetic procedures.

Competitive Landscape

The medical aesthetics industry is characterized by key players focusing on innovation, strategic collaborations, and regional expansion to maintain market leadership.

Companies are increasingly investing in research and development to introduce new products and technologies, particularly in minimally invasive procedures like dermal fillers and laser treatments. Strategic mergers and acquisitions are frequently employed to strengthen product portfolios and enhance market presence.

Additionally, many players are focusing on expanding their geographic footprint, particularly in emerging markets where the demand for aesthetic treatments is rising rapidly. Companies are also pursuing partnerships with dermatologists, plastic surgeons, and medical spas to drive the adoption of their products and expand their customer base.

Another key strategy includes increasing brand awareness through targeted marketing campaigns, leveraging social media influencers, and collaborating with beauty experts to build trust among consumers.

The adoption of advanced technologies such as Artificial Intelligence (AI) and Machine Learning (ML) in the development of aesthetic devices is also gaining traction, allowing for more precise and effective treatments.

• In January 2025, Aviva Aesthetics and Renew MedSpa partnered, expanding Aviva's footprint to the Midwest of the U.S. The collaboration aims to enhance Renew MedSpa's operations through access to financial support, marketing strategies, and supplier benefits, while allowing the spa to maintain ownership and autonomy under Aviva’s network of entrepreneurial med spa owners.

List of Key Companies in Medical Aesthetics Market:

• AbbVie Inc.
• Galderma
• Merz Pharma
• Johnson & Johnson Services, Inc.
• Bausch Health Companies Inc.
• Lumenis Be Ltd.
• Cynosure, LLC
• Sisram Medical Ltd
• Cutera, Inc.
• Lutronic Corporation
• Candela Corporation
• Aerolase
• Sciton
• El.En. S.p.A.
• BTL

Recent Developments (Acquisition/Product Launch)

• In March 2025, JeNaCell, an Evonik company, launched epicite CALM at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco. The product, the world’s first medical-grade post-treatment dressing made from biosynthetic cellulose, aims to establish a new standard of care following laser, light, and energy-based treatments, offering a sterile, hypoallergenic solution for improved patient recovery and safety.
• In September 2024, ARCHIMED acquired Jeisys Medical, a leading developer of non-invasive aesthetic medicine devices. The acquisition aims to support Jeisys Medical’s long-term global expansion in the energy-based device (EBD) segment, which includes technologies such as lasers, ultrasound, and radio frequencies for skin rejuvenation, fat reduction, and body contouring.